Sutton Wealth Advisors Inc. Collegium Pharmaceutical, Inc Transaction History

Sutton Wealth Advisors Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$23.0 - $29.88 $9,292 - $12,071	-404 Closed	0 $0
Q3 2022 Nov 07, 2023	SELL	$15.46 - $20.1 $1,020 - $1,326	-66 Reduced 14.04%	404 $6.47 Million
Q1 2022 Nov 07, 2023	BUY	$17.2 - $22.5 $7,894 - $10,327	459 Added 4172.73%	470 $9.57 Million
Q4 2021 Nov 07, 2023	BUY	$17.5 - $21.35 $192 - $234	11 New	11 $205,000
Q3 2021 Nov 07, 2023	SELL	$17.75 - $25.39 $6,585 - $9,419	-371 Closed	0 $0
Q2 2021 Nov 07, 2023	BUY	$21.74 - $25.28 $8,065 - $9,378	371 New	371 $8.77 Million

253

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $994M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.